PTEN Expression as a Complementary Biomarker for Mismatch Repair Testing in Breast Cancer.

Int J Mol Sci · 2020 · PMC7073136 · PMID 32098071

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

Remarkably, in HER2-enriched tumors ( n = 97), including Luminal B HER2+ ( n = 86) and HER2-type ( n = 11) intrinsic molecular subtypes, and ER-/HER2− ( n = 59) breast cancers, a highly significant association was observed.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.